Studies involving organoids have shown that introduction of mutations in genes coding for TGF-β, wingless-related integration site (Wnt), P53, and epidermal growth factor receptor (EGFR) promote tumor progression and metastasis [143]. This evidence concerns the gene EGFR and neoplasm.